In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer.

The effect of the PEG-grafted degree in the range of 0-30% on the in vitro macrophage uptake and in vivo biodistribution of poly(ethylene glycol)-poly(lactic acid)-poly(ethylene glycol) (PELE) nanoparticles (NPs) were investigated in this paper. The prepared NPs were characterized in terms of size, zeta potential, hydrophilicity, poly(vinyl alcohol) (PVA) residual on nanoparticles surfaces as well as drug loading. The macrophage uptake and biodistribution including plasma clearance kinetics following intravenous administration in mice of the NPs labeled by 6-coumarin were evaluated. The results showed that, except for the particles size, the hydrophilicity, superficial charges and in vitro phagocytosis amount of NPs are dependent on the PEG content in the copolymers greatly. The higher of the PEG content, the more hydrophilicity and the nearer to neutral surface charge was observed. And the prolonged circulation half-life (t(1/2)) of the PELE NPs in plasma was also strongly depended on the PEG content with the similar trend. In particular for PELE30 (containing 30% of PEG content) NPs, with the lowest phagocytosis uptake accompanied the highest hydrophilicity and approximately neutral charge, it had the longest half-life in vivo with almost 12-fold longer and accumulation in the reticuloendothelial system organs close to 1/2-fold lower than those of reference PLA. These results demonstrated that the PELE30 NPs with neutral charge and suitable size has a promising potential as a long-circulating oxygen carrier system with desirable biocompatibility and biofunctionality.

[1]  V. Labhasetwar,et al.  Characterization of nanoparticle uptake by endothelial cells. , 2002, International journal of pharmaceutics.

[2]  S. Moghimi,et al.  PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance , 2002, FEBS letters.

[3]  S. Moghimi,et al.  Capture of stealth nanoparticles by the body's defences. , 2001, Critical reviews in therapeutic drug carrier systems.

[4]  M C Davies,et al.  Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer. , 1997, Biomaterials.

[5]  R. Müller,et al.  'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.

[6]  P. Couvreur,et al.  Novel self-assembling nanogels: stability and lyophilisation studies. , 2007, International journal of pharmaceutics.

[7]  Qi Wang,et al.  Evaluation of blood compatibility of MeO‐PEG‐poly (D,L‐lactic‐co‐glycolic acid)‐PEG‐OMe triblock copolymer , 2006 .

[8]  Moghimi Sm,et al.  Serum factors that regulate phagocytosis of liposomes by Kupffer cells , 1993 .

[9]  R. Zhuo,et al.  Synthesis and gelation properties of PEG-PLA-PEG triblock copolymers obtained by coupling monohydroxylated PEG-PLA with adipoyl chloride. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[10]  M. Papisov,et al.  Why do Polyethylene Glycol-Coated Liposomes Circulate So Long?: Molecular Mechanism of Liposome Steric Protection with Polyethylene Glycol: Role of Polymer Chain Flexibility , 1994 .

[11]  Sung Wan Kim,et al.  Biodegradable thermosensitive micelles of PEG-PLGA-PEG triblock copolymers , 1999 .

[12]  Ick Chan Kwon,et al.  Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity. , 2006, Biomaterials.

[13]  S. Sahoo,et al.  Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Y. Bae,et al.  Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[15]  D. Fischer,et al.  Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  Michel Vert,et al.  Biodistribution of Long-Circulating PEG-Grafted Nanocapsules in Mice: Effects of PEG Chain Length and Density , 2001, Pharmaceutical Research.

[17]  Si-Shen Feng,et al.  Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. , 2005, Biomaterials.

[18]  S. Feng,et al.  Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Bailing Liu,et al.  A novel approach for the preparation of acrylate–siloxane particles with core–shell structure , 2007 .

[20]  O. Bourdon,et al.  Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules. , 2001, Biomaterials.

[21]  T. Park,et al.  Dexamethasone nano-aggregates composed of PEG-PLA-PEG triblock copolymers for anti-proliferation of smooth muscle cells. , 2006, International journal of pharmaceutics.

[22]  S. Venkatraman,et al.  ABA and BAB type triblock copolymers of PEG and PLA: a comparative study of drug release properties and "stealth" particle characteristics. , 2007, International journal of pharmaceutics.

[23]  A. Zahr,et al.  Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). , 2006, Langmuir : the ACS journal of surfaces and colloids.

[24]  M. Hashida,et al.  Macromolecular Carrier Systems for Targeted Drug Delivery: Pharmacokinetic Considerations on Biodistribution , 1996, Pharmaceutical Research.

[25]  Si-Shen Feng,et al.  Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery. , 2007, Biomaterials.

[26]  Jayanth Panyam,et al.  Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles. , 2003, International journal of pharmaceutics.

[27]  Fan Wu,et al.  Preparation of hemoglobin-loaded nano-sized particles with porous structure as oxygen carriers. , 2007, Biomaterials.

[28]  Jean-Pierre Benoit,et al.  Parameters influencing the stealthiness of colloidal drug delivery systems. , 2006, Biomaterials.

[29]  U. Bakowsky,et al.  Preparation and characterization of cationic PLGA nanospheres as DNA carriers. , 2004, Biomaterials.

[30]  S. Feng,et al.  Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. , 2004, Biomaterials.

[31]  Robert Gurny,et al.  Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[32]  S. Choi,et al.  Polymer brush-stabilized polyplex for a siRNA carrier with long circulatory half-life. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[33]  P. Vermette,et al.  Physico-chemical properties and cytotoxicity assessment of PEG-modified liposomes containing human hemoglobin. , 2008, Colloids and surfaces. B, Biointerfaces.

[34]  T. Allen.  A study of phospholipid interactions between high-density lipoproteins and small unilamellar vesicles. , 1981, Biochimica et biophysica acta.

[35]  S. Stolnik,et al.  COLLOIDAL STABILITY AND DRUG INCORPORATION ASPECTS OF MICELLAR-LIKE PLA-PEG NANOPARTICLES , 1999 .